Unknown

Dataset Information

0

Synthetic (N,N-Dimethyl)doxorubicin Glycosyl Diastereomers to Dissect Modes of Action of Anthracycline Anticancer Drugs.


ABSTRACT: Anthracyclines are effective drugs in the treatment of various cancers, but their use comes with severe side effects. The archetypal anthracycline drug, doxorubicin, displays two molecular modes of action: DNA double-strand break formation (through topoisomerase IIα poisoning) and chromatin damage (via eviction of histones). These biological activities can be modulated and toxic side effects can be reduced by separating these two modes of action through alteration of the aminoglycoside moiety of doxorubicin. We herein report on the design, synthesis, and evaluation of a coherent set of configurational doxorubicin analogues featuring all possible stereoisomers of the 1,2-amino-alcohol characteristic for the doxorubicin 3-amino-2,3-dideoxyfucoside, each in nonsubstituted and N,N-dimethylated forms. The set of doxorubicin analogues was synthesized using appropriately protected 2,3,6-dideoxy-3-amino glycosyl donors, equipped with an alkynylbenzoate anomeric leaving group, and the doxorubicin aglycon acceptor. The majority of these glycosylations proceeded in a highly stereoselective manner to provide the desired axial α-linkage. We show that both stereochemistry of the 3-amine carbon and N-substitution state are critical for anthracycline cytotoxicity and generally improve cellular uptake. N,N-Dimethylepirubicin is identified as the most potent anthracycline that does not induce DNA damage while remaining cytotoxic.

SUBMITTER: Wander DPA 

PROVIDER: S-EPMC8056385 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Synthetic (<i>N</i>,<i>N</i>-Dimethyl)doxorubicin Glycosyl Diastereomers to Dissect Modes of Action of Anthracycline Anticancer Drugs.

Wander Dennis P A DPA   van der Zanden Sabina Y SY   Vriends Merijn B L MBL   van Veen Branca C BC   Vlaming Joey G C JGC   Bruyning Thomas T   Hansen Thomas T   van der Marel Gijsbert A GA   Overkleeft Herman S HS   Neefjes Jacques J C JJC   Codée Jeroen D C JDC  

The Journal of organic chemistry 20210330 8


Anthracyclines are effective drugs in the treatment of various cancers, but their use comes with severe side effects. The archetypal anthracycline drug, doxorubicin, displays two molecular modes of action: DNA double-strand break formation (through topoisomerase IIα poisoning) and chromatin damage (via eviction of histones). These biological activities can be modulated and toxic side effects can be reduced by separating these two modes of action through alteration of the aminoglycoside moiety of  ...[more]

Similar Datasets

| S-EPMC7667640 | biostudies-literature
| S-EPMC8257780 | biostudies-literature
| S-EPMC8011376 | biostudies-literature
| S-EPMC9929489 | biostudies-literature
2016-04-04 | GSE63410 | GEO
| S-EPMC7663146 | biostudies-literature
| S-EPMC8159111 | biostudies-literature
| S-EPMC7015741 | biostudies-literature
2016-04-04 | E-GEOD-63410 | biostudies-arrayexpress
| S-EPMC4018067 | biostudies-literature